Solasta Bio

Glasgow, United Kingdom Founded: 2020 • Age: 6 yrs
Provider of pest control services and inputs
Annual revenue - Latest available
Total funding $20.8M 4 rounds
Employees 19 Tracked headcount
Investors 13 Known backers
Products - Services tracked
Competitors 4 Brand Intelligence

About Solasta Bio

Solasta Bio is a company based in Glasgow (United Kingdom) founded in 2020 by Paul Bernasconi, Julian Dow, and Shireen Davies. Solasta Bio has raised $20.76 million across 4 funding rounds from investors including University of Glasgow, Corteva Agriscience and Scottish Enterprise. The company has 19 employees as of March 31, 2024. Solasta Bio operates in a competitive market with competitors including DaBomb Protein, Innate Immunity and AgroMed, among others.

  • Headquarter Glasgow, United Kingdom
  • Employees 19 as on 31 Mar, 2024
  • Founders Paul Bernasconi, Julian Dow, Shireen Davies
  • Sectors
    Agriculture
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Solasta Bio Limited
  • Date of Incorporation 19 May, 2020
  • Jurisdiction GLASGOW, SCOTLAND
Operational Areas
Agriculture → Agricultural Technology & Innovation Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $20.76 M (USD)

    in 4 rounds

  • Latest Funding Round
    $14 M (USD), Series A

    Sep 11, 2024

  • Investors
  • Employee Count
    19

    as on Mar 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of Solasta Bio

Headcount 10-50
Employee Profiles 11
Employee Profiles
People
Shireen Davies
Chief Executive Officer
People
Yousef Abul-Haija
Research And Development Manager
People
Julian Dow
Chief Scientific Officer
People
Lewis Archibald
Team Leader (Chemistry)

Unlock access to complete

Funding Insights of Solasta Bio

Solasta Bio has successfully raised a total of $20.76M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $14 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Solasta Bio

Solasta Bio has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include University of Glasgow, Corteva Agriscience and Scottish Enterprise.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital firm focused on lifescience and healthcare sectors
Locked Locked Locked
Venture capital is provided by Cavallo Ventures in multiple sectors.
Locked Locked Locked
Impact investments are made in world-changing entrepreneurial ventures.
Locked Locked Locked
Premium access

Investor details for Solasta Bio

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Solasta Bio

Investments
Premium access

Investment portfolio details for Solasta Bio

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Solasta Bio

Premium access

Detailed financials for Solasta Bio

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Solasta Bio Comparisons

Solasta Bio Primary company
Description
Provider of pest control services and inputs
Location
Glasgow, United Kingdom
Founded Year
2020
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
19
As of 2024
Premium access

Peer comparison for Solasta Bio

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Solasta Bio

Solasta Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DaBomb Protein, Innate Immunity and AgroMed, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Manufacturer of protein food for pets
Locked Locked Locked
Biotechnology firm creating AMP platforms for disease resistance in health and agriculture sectors.
Locked Locked Locked
Utilizes lytic peptides to develop disease-resistant plants with improved nutritional content.
Premium access

Detailed competitors of Solasta Bio

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Solasta Bio

Premium access

Complete news archive for Solasta Bio

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Solasta Bio

Solasta Bio was founded in 2020 and raised its 1st funding round 1 year after it was founded.

Solasta Bio is headquartered in Glasgow, United Kingdom. It is registered at Glasgow, Scotland, United Kingdom.

Shireen Davies is the current CEO of Solasta Bio. They have also founded this company.

Solasta Bio is a funded company, having raised a total of $20.76M across 4 funding rounds to date.

As of Mar 31, 2024, the latest employee count at Solasta Bio is 19.

Solasta Bio was founded in 2020 in Glasgow, United Kingdom. Operations focus on the biotechnology sector for agriculture. Insect control peptides are developed to disrupt functions in target pest species. Beneficial insects and vertebrates are left unaffected by these solutions. Pest control services and related inputs are offered through this platform to support sustainable management practices.

Solasta Bio's top competitors include DaBomb Protein, Innate Immunity and AgroMed.

Solasta Bio has 13 investors. Key investors include University of Glasgow, Corteva Agriscience, Scottish Enterprise, UPL, and FMC Corporation.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available